On the other hand, Cui et al. (2017) provided evidence that survivin is positioned at the downstream in NF-κB signaling pathway a in bladder cancer progression, NF-κB activation enhances the expression of survivin both in vitro and in vivo. The gene discussed is BIRC5; the disease is urinary bladder carcinoma.